NEW YORK / Nov 26, 2025 / Business Wire / DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in December:
Noble Capital Markets Emerging Growth Conference (December 3rd)
Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings and deliver a presentation on Wednesday, December 3rd at 1:00 PM ET. A webcast of the event will be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.
Citi’s 2025 Global Healthcare Conference (December 4th)
Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings at this event.
iAccess Alpha Best Ideas Conference (December 9th – 10th)
Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings and deliver a presentation on Tuesday, December 9th at 1:00 PM ET. A webcast of the event will be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.
About DocGo
DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring, ambulance services and a 50-state virtual care network. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo’s proprietary technology and relationships with a dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient’s home or workplace. Together with DocGo’s integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com. To get an inside look on how the proactive healthcare revolution is helping transform healthcare by reducing costs, increasing efficiency and improving outcomes, visit www.proactivecarenow.com.
| Last Trade: | US$1.03 |
| Daily Change: | -0.01 -0.96 |
| Daily Volume: | 384,544 |
| Market Cap: | US$100.740M |
November 10, 2025 November 04, 2025 October 20, 2025 October 16, 2025 August 07, 2025 | |

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load